Oracle was at the center of all things artificial intelligence (AI) in 2025, and therefore at the center of the investing ...

Oracle’s cloud and AI pivot drives revenue growth and a strong backlog, but high capex and debt pose risks. Read why I rate ...

Oracle (NYSE:ORCL) looked set to be the newest addition to the $1 trillion club just a few months back in September, where ...

Oracle founder, 81, has agreed to personally guarantee up to $40.4 billion to backstop Paramount Skydance’s all-cash bid for ...

What Happened: Magouyrk's decision to sell 10,000 shares of Oracle was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday. The total value of the sale is ...

Oracle's 2052 bonds are offering a rare 7% yield. Read about the risks and if they're right for income-focused investors.

Hospitals and health systems are entering a period of rapid acceleration in AI. Clinical leaders are reporting tangible gains, from automated note-taking to clearer visibility into patient histories, ...

Oracle founder Larry Ellison agreed to backstop $40.4 billion in capital for Paramount Skydance's attempted acquisition of ...

Oracle Health, the nation’s second-largest EHR vendor by market share, had a busy December, with health system project and AI customer expansions. Here are 11 times Becker’s reported on the company in ...

Larry Ellison began 2025 as one of the richest people in the world. He briefly held first place during the year and saw his ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...